Modular point-of-care devices, systems, and uses thereof

US11366106B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-11366106-B2
Application numberUS-201615069843-A
CountryUS
Kind codeB2
Filing dateMar 14, 2016
Priority dateOct 2, 2007
Publication dateJun 21, 2022
Grant dateJun 21, 2022

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

The present invention provides devices and systems for use at the point of care. The methods devices of the invention are directed toward automatic detection of analytes in a bodily fluid. The components of the device are modular to allow for flexibility and robustness of use with the disclosed methods for a variety of medical applications.

First claim

Opening claim text (preview).

What is claimed is: 1. A system for performing an assay capable of detecting at least two analytes present in a sample, the device comprising: a cartridge comprising: a plurality of reagent units for storing cartridge reagents used to detect the at least two analytes; and a sample vessel configured to receive the sample; a plurality of assay assemblies, a first assay assembly of the plurality of assay assemblies comprising: an addressable assay unit configured to receive the sample and to receive a cartridge reagent from a reagent unit of the plurality of reagent units of the cartridge, wherein the addressable assay unit comprises an interior reaction site having thereon an immobilized binding reagent such that a reaction occurs within the assay unit that is configured to yield a detectable signal indicative of a presence of a first analyte in the sample; and an assembly tip in fluid communication with the addressable assay unit and comprising an opening, wherein the assembly tip is configured to place the addressable assay unit in fluid communication with the reagent unit of the plurality of reagent units or the sample vessel of the cartridge; an automated fluid transfer device configured to move the first assay assembly relative to the cartridge to selectively place the assembly tip of the first assay assembly into the sample vessel or into the reagent unit of the plurality of reagent units and to direct transfer of the sample or the cartridge reagent into the addressable assay unit via the assembly tip in a sequence according to a predetermined protocol for detecting the first analyte such that a reaction occurs within the addressable assay unit. 2. The system of claim 1 , wherein the cartridge further comprises a housing for holding the plurality of reagent units. 3. The system of claim 1 , wherein the plurality of reagent units comprise instrument-operable containers that encapsulate the cartridge reagents. 4. The system of claim 1 , wherein the cartridge reagents include liquid-phase and solid-phase reagents. 5. The system of claim 1 , wherein the cartridge further comprises at least one storage area to store waste from performing the assay. 6. The system of claim 1 , wherein the sample comprises a fingerstick blood sample. 7. The system of claim 1 , wherein the cartridge further comprises a cartridge identifier. 8. The system of claim 1 , wherein the cartridge further comprises a beads well. 9. The system of claim 1 , wherein the interior reaction site of the assay unit is transparent. 10. The system of claim 1 , wherein the sample is a bodily fluid sample, and wherein the immobilized binding reagent is an antibody or an antigen. 11. The system of claim 1 , wherein a second assay assembly of the plurality of assay assemblies comprises: a second addressable assay unit configured to receive the sample from the sample vessel and a second cartridge reagent from a second reagent unit of the plurality of reagent units of the cartridge, wherein the second addressable assay unit comprises an interior reaction site having thereon an immobilized binding reagent that is configured to yield a detectable signal indicative of a presence of a second analyte in the sample; and a second assembly tip in fluid communication with the second addressable assay unit and comprising an opening, wherein the second assembly tip is configured to place the second addressable assay unit in fluid communication with the second reagent unit of the plurality of reagent units or the sample vessel of the cartridge. 12. The system of claim 11 , wherein the automated fluid device is configured to move the second assay assembly relative to the cartridge to selectively place the second assembly tip of the second assay assembly into the sample vessel or into the second reagent unit of the plurality of reagent units and to direct transfer of the sample or the second cartridge reagent into the second addressable assay unit via the second assembly tip in a sequence according to a predetermined protocol for detecting the second analyte such that a reaction occurs within the second addressable assay unit. 13. The system of claim 1 , wherein the automated fluid transfer device comprises a plurality of heads configured to engage the plurality of assay assemblies. 14. A system for performing an assay capable of detecting at least two analytes present in a sample, the system comprising: a cartridge comprising: a plurality of reagent units for storing cartridge reagents used to detect the at least two analytes; and a sample vessel configured to receive the sample; a plurality of assay assemblies, a first assay assembly of the plurality of assay assemblies comprising: an addressable assay unit for receiving a cartridge reagent from a reagent unit of the plurality of reagent units and the sample from the sample vessel, wherein the addressable assay unit comprises an interior reaction site having thereon an immobilized binding reagent such that a reaction occurs within the assay unit that is configured to yield a detectable signal indicative of a presence of a first analyte in the sample; and an assembly tip in fluid communication with the addressable assay unit and comprising an opening at a bottom of the assembly tip for transfer of the cartridge reagent and the sample from the cartridge into the addressable assay unit; and a reader assembly configured to receive the cartridge and the first assay assembly, the reader assembly comprising an automated fluid transfer device configured to move the first assay assembly relative to the cartridge and to selectively place the assembly tip of the first assay assembly into the sample vessel or into the reagent unit of the plurality of reagent units and to direct transfer of the sample or the cartridge reagent into the addressable assay unit via the assembly tip. 15. The system of claim 14 , wherein the cartridge further comprises a housing for holding the plurality of reagent units. 16. The system of claim 14 , wherein the plurality of reagents include liquid-phase and solid-phase reagents. 17. The system of claim 14 , wherein the assembly tip tapers towards the bottom of the assembly tip. 18. A system for performing an assay to detect whether an analyte is present in a sample, comprising: a cartridge comprising a housing defining a plurality of reagent units for storing cartridge reagents and a sample vessel configured to receive a sample; an assay assembly comprising an assay unit configured to run a reaction to detect whether an analyte is present in the sample, and a tubular tip in fluid communication with the assay unit; wherein the assay unit comprises an interior reaction site having an immobilized binding reagent such that when the analyte is present in the sample, and when the sample and at least one cartridge reagent from at least one reagent unit of the plurality of reagent units are transferred to the assay unit, a reaction occurs within the assay unit that produces a detectable signal indicative of the presence of the analyte in the sample; and an automated fluid transfer device having a head configured to couple to the assay assembly, wherein the automated fluid transfer device moves the assay assembly relative to the cartridge and directs transfer of the sample and the cartridge reagents from the cartridge into the assay unit through the tubular tip. 19. The system of claim 18 , wherein the assay unit and the tubular tip are integrally formed.

Assignees

Inventors

Classifications

  • involving compounds serving as markers for tumours, cancers or neoplasias, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides or metabolites · CPC title

  • Analytical elements · CPC title

  • Interchangeable or disposable dispensing tips · CPC title

  • Multiple transfer devices · CPC title

  • using disposable tips · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US11366106B2 cover?
The present invention provides devices and systems for use at the point of care. The methods devices of the invention are directed toward automatic detection of analytes in a bodily fluid. The components of the device are modular to allow for flexibility and robustness of use with the disclosed methods for a variety of medical applications.
Who is the assignee on this patent?
Labrador Diagnostics Llc
What technology area does this patent fall under?
Primary CPC classification G01N35/028. Mapped technology areas include Physics.
When was this patent published?
Publication date Tue Jun 21 2022 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 12 related publications on this page (citations in our corpus or others sharing the same primary CPC).